-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
-
Summary
-
Vertex Pharmaceuticals Inc / Ma quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2010 to Q4 2022.
- Vertex Pharmaceuticals Inc / Ma Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2022 was $77.4M, a 27.4% decline year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)